Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

EFFICACY AND SAFETY OF ENDOSCOPIC DACRYOCYSTORHINOSTOMY IN PATIENTS WITH NASOLACRIMAL DUCT OBSTRUCTION: EXPERIENCE AT TERTIARY CARE HOSPITAL, PESHAWAR

View through CrossRef
Objective: To determine the safety and efficacy of Endoscopic Dacryocystorhinostomy in patients with nasolacrimal duct obstruction. Methods: The prospective non-randomized non-comparative observational study was conducted at Department of Ear Nose Throat and Head & Neck Surgery, Khyber Teaching Hospital, Peshawar, from June 2024 to May 2025 and observed patients of acute/ chronic dacryocystitis, who underwent endoscopic endonasal dacryocystorhinostomy, for the outcome of procedure. Endoscopic dacryocystorhinostomy (DCR), with or without the use of lacrimal intubation, was carried out under general anesthesia. The patients were followed up post-operatively at 1 month and 6 months. Data was analyzed using SPSS 24. Results: A total 54 eyes of 50 patients (56% males) underwent endoscopic dacryocystorhinostomy, with mean age of 37.3 ± 12.12years. Primary procedures were performed in 90% patients and 10% were revision cases. Unilateral surgeries accounted for 92%, with stents used in 44% of eyes. Mean operative time was 61.5 ± 40.6minutes. Concurrent nasal procedures were done in 22%.Post-operatively, patients were discharged within/ after 12 hours. At six-month follow-up, both anatomical and functional success were achieved in 96% of patients. Recurrent dacryocystitis occurred in 4% patients. Significant intra-operative bleeding was seen in 6%, with no major complications reported. Conclusion: Endoscopic DCR is a safe and effective surgical option for nasolacrimal duct blockade. The use of stents is primarily determined by the anatomical site of the obstruction. Bilateral cases can be treated simultaneously, with outcomes and success rates similar to those of unilateral procedures.
Title: EFFICACY AND SAFETY OF ENDOSCOPIC DACRYOCYSTORHINOSTOMY IN PATIENTS WITH NASOLACRIMAL DUCT OBSTRUCTION: EXPERIENCE AT TERTIARY CARE HOSPITAL, PESHAWAR
Description:
Objective: To determine the safety and efficacy of Endoscopic Dacryocystorhinostomy in patients with nasolacrimal duct obstruction.
Methods: The prospective non-randomized non-comparative observational study was conducted at Department of Ear Nose Throat and Head & Neck Surgery, Khyber Teaching Hospital, Peshawar, from June 2024 to May 2025 and observed patients of acute/ chronic dacryocystitis, who underwent endoscopic endonasal dacryocystorhinostomy, for the outcome of procedure.
Endoscopic dacryocystorhinostomy (DCR), with or without the use of lacrimal intubation, was carried out under general anesthesia.
 The patients were followed up post-operatively at 1 month and 6 months.
Data was analyzed using SPSS 24.
Results: A total 54 eyes of 50 patients (56% males) underwent endoscopic dacryocystorhinostomy, with mean age of 37.
3 ± 12.
12years.
Primary procedures were performed in 90% patients and 10% were revision cases.
Unilateral surgeries accounted for 92%, with stents used in 44% of eyes.
Mean operative time was 61.
5 ± 40.
6minutes.
Concurrent nasal procedures were done in 22%.
Post-operatively, patients were discharged within/ after 12 hours.
At six-month follow-up, both anatomical and functional success were achieved in 96% of patients.
Recurrent dacryocystitis occurred in 4% patients.
Significant intra-operative bleeding was seen in 6%, with no major complications reported.
Conclusion: Endoscopic DCR is a safe and effective surgical option for nasolacrimal duct blockade.
The use of stents is primarily determined by the anatomical site of the obstruction.
Bilateral cases can be treated simultaneously, with outcomes and success rates similar to those of unilateral procedures.

Related Results

Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature
Abstract Introduction Thoracic duct cysts are an uncommon phenomenon, especially within the cervical region. Due to its limited reported cases, very little is known about its etiol...
Efficacy and Safety of Adjunctive Triamcinolone in Nasal Endoscopic Dacryocystorhinostomy
Efficacy and Safety of Adjunctive Triamcinolone in Nasal Endoscopic Dacryocystorhinostomy
Objective: To assess safety and long-term efficacy of use of triamcinolone acetonide (TA) soaked absorbable gel foam dressing in Endoscopic Dacryocystorhinostomy in our population....
comparative analysis: Success rates of Endoscopic Endonasal versus External Dacryocystorhinostomy with silicon tube.
comparative analysis: Success rates of Endoscopic Endonasal versus External Dacryocystorhinostomy with silicon tube.
Introduction: Dacryocystorhinostomy (DCR) is a standard surgical treatment for nasolacrimal duct obstruction. it can be performed via external (E-DCR) or internal (EE-DCR) approac...
Endoscopic Dacryocystorhinostomy With Ologen Implant
Endoscopic Dacryocystorhinostomy With Ologen Implant
Abstract Objective: To compare the effectiveness of endoscopic dacryocystorhinostomy with ologen implant versus endoscopic dacryocystorhinostomy with silicon tube implantat...
Isolated cystic duct cyst in a child :A case report
Isolated cystic duct cyst in a child :A case report
Abstract Background: Dilatation of the common bile duct is a common biliary malformation in children. However, isolated cysts of the cystic duct are extremely rare and not ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Dacryocystorhinostomy Stent Insertion in Initial Endoscopic Dacryocystorhinostomy
Dacryocystorhinostomy Stent Insertion in Initial Endoscopic Dacryocystorhinostomy
ABSTRACT Aim To study surgical outcome in dacryocystorhinostomy (DCR) stent insertion in initial endoscopic DCR and the complications associated with the surgery. Study design T...

Back to Top